The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice
Open accessAbstract
The neurotrophin brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin-related kinase B (TrkB) have emerged as key mediators in the pathophysiology of several mood disorders, including anxiety and depression. However, therapeutic compounds that interact with TrkB receptors have been difficult to develop. Using a combination of structure-based in silico screening and high-capacity functional assays in recombinant and neuronal cells, we identified a low-molecular weight TrkB ligand (ANA-12) that prevented activation of the receptor by BDNF with a high potency. ANA-12 showed direct and selective binding to TrkB and inhibited processes downstream of TrkB without altering TrkA and TrkC functions. KIRA-ELISA analysis demonstrated that systemic administration of ANA-12 to adult mice decreased TrkB activity in the brain without affecting neuronal survival. Mice administered ANA-12 demonstrated reduced anxiety- and depression-related behaviors on a variety of tests predictive of anxiolytic and antidepressant properties in humans. This study demonstrates that structure-based virtual screening strategy can be an efficient method for discovering potent TrkB-selective ligands that are active in vivo. We further propose that ANA-12 may be a valuable tool for studying BDNF/TrkB signaling and may constitute a lead compound for developing the next generation of therapeutic agents for the treatment of mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“ANA-12 is a selective partial agonist that was first developed by Carzola et al. in 2011 using a structure-based in silico screening (Cazorla et al. 2011).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Cazorla et al. 2011
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, when PC12 cells transfected with TrkB were stimulated with BDNF for 48 h, neurite outgrowth was increased compared to the non-treated cells (Cazorla et al. 2011).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Cazorla et al. 2011
The cited source says what the claim attributes to it.
In the citing paper
“In their study, the authors identified a low-molecular weight antagonist of TrkB that could induce anxiolytic and antidepressant properties.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Cazorla et al. 2011
The cited source says what the claim attributes to it.
In the citing paper
“In spite of these interesting results, antagonists could also induce cell death, an issue that should be addressed when considering using these agents in chronic treatment regimens (Cazorla et al. 2011; Takemoto et al. 2015).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Cazorla et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang, W., Yang, R., Cieplak, P., Luo, R., Lee, T.-S., et al. (2003) · Journal of Computational Chemistry · doi:10.1002/jcc.10349 · Cited by 4,271
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,836
The use of a plus-maze to measure anxiety in the mouse
Lister, R. G. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,617
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Lister, 1987, Psychopharmacology (Berl)., 92, 180
- Porsolt, 1977, Arch Int Pharmacodyn Ther., 229, 327
Cited by
Sorted by citations
Items 301–394 of 394
Miller, K. E., Wood, W. E., Brenowitz, E. A., & Perkel, D. J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2375-19.2019 · Cited by 6
Altered GABAergic inhibition in CA1 pyramidal neurons modifies despair-like behavior in micePreprint
Yoon, S. H., Chung, G., Song, W. S., Oh, S. P., Kim, J.-J., Kim, S. J., & Kim, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.18.953786 · Cited by 7
Velasco-Gutiérrez, J. A., de Álvarez-Buylla, E. R., Montero, S., Rodríguez‐Hernández, A., Miranda, S. L., Martínez-Santillan, K., Álvarez-Valadez, M. D. R., Lemus, M., Flores-Silva, A., & Virgen‐Ortiz, A. (2025) · Biomedicines · doi:10.3390/biomedicines13010126 · Cited by 5
Zhang, L., Wei, T., Liu, X., Zhang, L., Wang, D., Luo, Y., He, Y., He, Z., & Zeng, F. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01334-y · Cited by 5
Ascone, F., Buzzelli, V., Mottarlini, F., Trapano, M. D., Miglioranza, P., Rava, A., Feo, A., Spano, F., Hausman, M., Sugaya, K., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02361-x · Cited by 5
Dhakal, S., He, L., Lyuboslavsky, P. N., Sidhu, C. S., Chrenek, M. A., Sellers, J. T., Boatright, J. H., Geisert, E. E., Setterholm, N. A., McDonald, F. E., et al. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2020.7392 · Cited by 5
Interference of neuronal TrkB signaling by the cannabis-derived flavonoids cannflavins A and B
Holborn, J., Mooradally, A. W., Perrin, C. J., Alural, B., Aitchison, C., Borenstein, A., Jones, N., Khokhar, J. Y., Akhtar, T. A., & Lalonde, J. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100410 · Cited by 6
rTMS Modulation of Behavioral and Biological Measures in 3xTg-AD Mice
Kraybill, E. P., Mojabi, F. S., Heath, A. M., Spikes, C. R., Beard, C., & McNerney, M. W. (2024) · Brain Sciences · doi:10.3390/brainsci14121186 · Cited by 5
Pereira, G. C., Roversi, K., Trevisan, G., Bürger, M. E., & Bochi, G. V. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000547 · Cited by 7
Liu, L., Hao, M., Yu, H., Tian, Y., Yang, C. Z., Fan, H., Zhao, X., Geng, F., Mo, D., Xia, L., et al. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-01984-3 · Cited by 4
Soejima, T., Hoshino, K., & Morimoto, Y. (2025) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007572 · Cited by 5
Teng, Y., Tien-Wei, H., Peng, W.-H., Wu, C.-C., Chu, T., Lee, Y., Lee, M. T., & Ho, Y. (2026) · Antioxidants · doi:10.3390/antiox15010139 · Cited by 4
Heles, M., Pasvolsky, L., Sathishkumar, H. N., Na’ara, S., Vu, Y., Stewart, C. L., Xie, T., Gleber‐Netto, F. O., McCarthy, W. C., Yaniv, D., et al. (2026) · Science · doi:10.1126/science.aec6116 · Cited by 4
Meng, K., Zhao, Z.-R., Gao, Y., Wu, K., Liu, W., Wang, X., Zheng, Y., Zhao, W., & Wang, B. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1469775 · Cited by 4
Sims, S., Rizzo, A., Kinley-Howard, K., Farrand, A. Q., Boger, H. A., & Adkins, D. L. (2020) · Neurorehabilitation and neural repair · doi:10.1177/1545968320952798 · Cited by 4
Sexual motivation in male rats is modulated by tropomyosin receptor kinase B (TrkB).
Hawley, W. R., & Mosura, D. E. (2018) · Behavioral Neuroscience · doi:10.1037/bne0000286 · Cited by 4
Martínez‐Mármol, R., Chai, Y., Khan, Z., Kim, S. B., Hong, S. M., Gormal, R. S., Lee, D. H., Lee, J. K., Lee, M. K., Kim, S. Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.271676 · Cited by 4
Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131129fb · Cited by 4
Truncated TrkB: The predominant TrkB isoform in nociceptors
Merlo, J., Chang, F.-M., Tran, M., Alfaro, J., Ibrahim, T., Wu, P., & Ruparel, S. B. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105409 · Cited by 3
Ohta, K., Ujihara, H., Kumei, H., Suzuki, S., Otabi, H., Warita, K., & Miki, T. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115790 · Cited by 3
BDNF exerts an NRF2-dependent cytoprotective function via a receptor-independent pathway
Fath, J., Brouillard, F., Claverie, D., Cabayé, A., Nuss, P., Chwetzoff, S., Coppée, R., Bouceba, T., Bouvier, E., Poillerat, V., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116587 · Cited by 3
Shi, X., Cai, S., Chai, J.-L., Xu, C. J., Zhou, B.-Y., Han-qi, L., Marshall, J., & Cao, C. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03575-7 · Cited by 3
Seyedi, F., Hedayati‐Moghadam, M., Heidari, M., Golkar, A., & Baghcheghi, Y. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103465 · Cited by 3
Neurochemical Signaling in Depression: Impact of Target-Based Pharmaceuticals
Sharma, B., & Khushboo (2022) · Current Drug Therapy · doi:10.2174/1574885517666220817122840 · Cited by 3
Leggieri, A., García‐González, J., Hosseinian, S., Ashdown, P., Anagianni, S., Wang, X., Havelange, W., Fernàndez‐Castillo, N., Cormand, B., & Brennan, C. H. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03703-x · Cited by 3
Small-molecule neurotrophin antagonist reduces anxiety
Harrison, C. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3470 · Cited by 3
The involvement of neuronal chloride transporter deficiencies in epilepsy
Sullivan, B. J., & Kadam, S. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815318-5.00014-5 · Cited by 3
Stress Responsiveness of BDNF/TrkB Signaling in the Neuroendocrine System and Future Implications
Azogu‐Sepe, I., & Plamondon, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813156-5.00013-3 · Cited by 3
BDNF/TrkB Signaling and Epileptogenesis
Harward, S. C., Huang, Y. Z., & McNamara, J. O. (2024) · doi:10.1093/med/9780197549469.003.0032 · Cited by 2
Long-term functional rescue of trauma-induced vision loss by a novel, small molecule TrkB modulator
Modgil, S., Walker, C. J., Chrenek, M. A., Grossniklaus, H. E., McDonald, F. E., & Iuvone, P. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320231 · Cited by 2
TrkB and the calpain dependent-Tc TrkB receptor isoforms: possible neurological therapeutic targets
Mascó, D. H. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/7.1076 · Cited by 2
Nguyen, D. D., Mansur, S., Ciesla, L. M., Gray, N. E., Zhao, S., & Bao, Y. (2024) · Molecules · doi:10.3390/molecules29173992 · Cited by 2
Iimura, A., Nishida, E., & Kusakabe, M. (2019) · Genes to Cells · doi:10.1111/gtc.12740 · Cited by 3
Neurotrophic Factors and Ethanol Neurotoxicity
Davis, M. I. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_47 · Cited by 2
Hashimoto, K. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_37 · Cited by 2
The Transition from Acute to Chronic Pain
Sun, W., Su, Y.-S., & Chen, C. (2019) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190860509.013.28 · Cited by 3
Hany, R., Leyris, J.-P., Bret, G., Mallié, S., Sar, C., Thouaye, M., Hamzé, A., Provot, O., Sokoloff, P., Valmier, J., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00048 · Cited by 2
Self-citationA receptor-independent signaling pathway for BDNFPreprint
Fath, J., Brouillard, F., Cabayé, A., Claverie, D., Nuss, P., Poillerat, V., Chwetzoff, S., Bouceba, T., Bouvier, E., Salameh, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.23.504973 · Cited by 2
Shiu, F. H., Skelton, H. M., Berglund, K., Fernandez, A. M., Gutekunst, C., Robinson, E. R., Wang, Z., & Gross, R. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.17.512538 · Cited by 2
Becker, H. C., Solomon, M. G., Gano, A., & Lopez, M. J. (2025) · Research Square · doi:10.21203/rs.3.rs-8735131/v1 · Cited by 2
Antonijevic, M., Santos, J. S. O., Dallemagne, P., & Rochais, C. (2024) · Molecular Informatics · doi:10.1002/minf.202400043 · Cited by 1
Uju, C. N., & Unniappan, S. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112703 · Cited by 1
Lenci, A., Villa, M., Scolz, A., Birolini, G., Conforti, P., Pepe, G., Castagno, A. N., Cassarino, C., Colombo, L., Favagrossa, M., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108375 · Cited by 1
Fagan, A., Sponchiado, M., Mata, L., Amin, S., Aguirre, J. I., Prabhakaran, S., & Reznikov, L. R. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1578553 · Cited by 1
Preclinical study of cannflavins A and B action against glioblastoma cells
Holborn, J., Robeson, H. N., Chartley, E., Gluscevic, T., Borenstein, A., Perrin, C. J., Alural, B., Perera, H., Akhtar, T. A., Jones, N., et al. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.100967 · Cited by 1
[Anatomo-echocardiographic correlation of scimitar syndrome in adults].
Espinola-Zavaleta, N. G., Muñoz‐Castellanos, L., Játiva-Chávez, S., & Zamora-González, C. (2005) · PubMed · Cited by 4
Epigenetics in mental and neurodegenerative disorders
Iatrou (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180712ai · Cited by 1
Neurodevelopmental alterations in a mouse model of maternal immune activation
Fernandez, A. (2018) · theses.fr (ABES) · doi:10.70675/502cd79bzfc73z4f21z8675z5dea9ddf93e0 · Cited by 1
Hung, J. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/27087
The Neuroprotective Potential of STN DBS and the Role of BDNF
Fischer, D. L. (2015) · Michigan State University Libraries · doi:10.25335/m5s778
Ibáñez, T. V. O. (2014) · TDX (Tesis Doctorals en Xarxa)
BDNF-Induced Intracellular Signaling
Gomes, J. R., Lobo, A. C., Duarte, C. B., & Grãos, M. (2017) · Neuromethods · doi:10.1007/7657_2017_6
Role of TrkB-signaling in taste development and function.
Rios-Pilier, J. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3128
Mechanisms Underlying Maintenance of Adult Visual Receptive Fields
Mudd, D. B. (2022) · Digital Archive @ GSU · doi:10.57709/14967304
A Web-Based Autonomous Learning System for Engineering Graphics Education
Song, W., Yang, B., Cao, S., Song, K., & Lv, J. (2011) · International Workshop on Education Technology and Computer Science · doi:10.1109/etcs.2011.215
TrkB Activators for the Treatment of Traumatic Vision Loss
Iuvone, P. M., & Diamond, B. (2013) · doi:10.21236/ada606287
Faculty Opinions recommendation of Psychedelics promote structural and functional neural plasticity.
Chapman, E. R., & Vevea, J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733441066.793547403
Li, J., Sun, Y., Su, Y., Wang, Q., Wang, T., Zheng, J.-Y., Zhang, C., Liu, X., Ma, Y., Li, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2291445/v1
Brain Derived Neurotrophic Factor (BDNF) as a Mediator of Microglia-Induced Neuroinflammation
Charlton, T. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-15264
Palma, M. D., Lattanzi, D., Ambrogini, P., & Sartini, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41441
Lozano-Ureña, A., Llabrés-Mas, A. M., Ramón‐Landreau, M., Fraj, A., Sánchez‐Puelles, C., Garrido‐García, A., Cano‐Daganzo, V., Valdés-Lora, L., & Frade, J. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.17.628978
Chen, E. Y., Chen, Y., & Lin, Y. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19966
Long-Term Functional Rescue of Trauma-Induced Vision Loss by a Novel, Small Molecule TrkB ActivatorPreprint
Modgil, S., Walker, C. J., Chrenek, M. A., Grossniklaus, H. E., McDonald, F. E., & Iuvone, P. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.18.638863
Ketamine’s Multifaceted Neuropharmacological and Neurobiological Actions
Kohtala, S., & Annala, I. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_2
Application of synthetic biology in age-related and neurodegenerative disease
Ghosh, S., Kundu, S., Jana, R., Basu, B., & Prajapati, B. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33649-2.00011-3
Kim, J. H., Kim, S.-S., Lee, E. H., Oh, S.-J., Hong, G.-S., Lee, B., Cho, I., Choi, C. W., Kang, T., & Kim, M. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178363
Liu, B., Liu, Y., Li, S., Chen, P., Zhang, J., & Feng, L. (2023) · Figshare · doi:10.6084/m9.figshare.22715359
Rathore, D., Shrimali, V., Naha, N., & Shivgotra, V. K. (2026) · F&S Science · doi:10.1016/j.xfss.2025.11.003
Tan, P., Fu, X., Lin, S., Yu, X.-D., Luo, J., Baran, M. R., Reilly, J., He, Z., & Shu, X. (2026) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2026.108141
Su, D., Qi, Q., Li, J., & Zhang, X. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110917
Hsiao, K. (2026) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2026.1753562
Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusionsPreprint
Contreras-Zarate, M. J., Jaramillo-Gómez, J. A., Marquez-Ortíz, R. A., Pham, T. C., Koliavas, S. N., Ormond, D. R., Navarro, A., Nemenoff, R. A., Camidge, D. R., & Cittelly, D. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.18.711213
From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation
Vishwapriya, A. K., Verma, K., Sharma, G., Sindhu, N., Paliwal, S., Jain, S., Dwivedi, J., Paliwal, S., & Sharma, S. K. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05204-0
Epigenetic regulation of BDNF-TRKB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · theses.fr (ABES) · doi:10.70675/7796cc83z9f91z48c6zadb1zb6a90897b5d5
KCC2 into the spotlight : from physiology to pathology
Hamze, M. (2023) · theses.fr (ABES) · doi:10.70675/25267775zf815z4920zb957zd68879fc263e
Sims, S., Hong, A., Akirtava, M., Camburn, K., Pawar, R., Strickland, C. N., Burke, E., Pfohl, E. B., & McKnight, M. (2026) · Developmental Neuroscience · doi:10.1159/000552025
Traumatic life experiences during critical periods lead to diverse developmental trajectories
Morelli, G., Visintin, G., Gelli, E., Serani, A., Bartolucci, M., Uccella, S., D’APRUZZO, M., Preiti, D., Chellali, M. M., Cucinelli, A., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102798
Li, X., Yuan, L., Zuo, Y., Li, X., Jin, T., Cheng, L., Chu, H., & Zhang, T. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122074
Sloan, O., Orr, S., & Rajagopalan, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731794
Takasaki, I., Inoue, A., Yoshida, A., Ashihara, Y., & Mori, H. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00880-4
Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
Contreras-Zarate, M. J., Jaramillo-Gómez, J. A., Marquez-Ortíz, R. A., Pham, T. C., Koliavas, S. N., Ormond, D. R., Navarro, A., Nemenoff, R. A., Camidge, D. R., & Cittelly, D. M. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0811
Aránguiz-Barrera, J., Moreira-Banuth, A. M., Zepeda-Morales, K., Triolo, M., Oneto, N. I., Bravo, D., Huidobro-Toro, J. P., Donoso, M. V., Noseda, R., Pélissier, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146510
Neurotrophic Glucocorticoid Signalling
Jeanneteau, F. D. (2026) · Receptors · doi:10.3390/receptors5030024
Jia, S., Rybalchenko, N., Paundralingga, O. T. K., Appiah, C. B., Farmer, G. E., & Cunningham, J. T. (2026) · Journal of Neurophysiology · doi:10.1152/jn.00265.2026
MEF2D as a key regulator of osteoarthritis with exploratory therapeutic potential
Dai, J., Gong, X., Tang, H., Hu, Z., 杨莎, He, Y., Deng, J., Liu, L., Hu, W., Dai, Q., et al. (2026) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2026.08.011
Bodur, A., Zihni, H. Ç., Korkmaz, K., Bodur, S., & Alver, A. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.71104
A De Novo Peptide That Induces Axonal Growth Through TrkB Activation
Maini, R., Tamada, K., Fukuda, K., Takumi, T., & Suga, H. (2026) · ChemBioChem · doi:10.1002/cbic.70517
Wang, X., Ding, Y., He, L., Kang, X.-Z., Geng, X., Sakaue, F., Yokota, T., Zhang, L., Yao, W., & Zhang, J. (2026) · Aging Cell · doi:10.1111/acel.70717
Sex-specific spinal neurotrophin receptors mediate chronic stress-induced tactile allodynia in rats
Escoto-Rosales, M. J., Crisóstomo-Jiménez, A., Pizaña-Encarnación, J. M., Guerrero-Morán, R. E., Curiel-Gomez, E., Rodríguez-Palma, E. J., Islas-Espinoza, A. M., Herrera‐Perez, J. J., Fernández‐Guasti, A., Caram‐Salas, N. L., et al. (2026) · Journal of Pain · doi:10.1016/j.jpain.2026.106449
Xu, N., Du, C., Li, Y., Yang, W., Li, W., Perez, R. G., Yu, S., & Lou, H. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111227
Wlodarek, L., & Li, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.15.759429
BindingDB (2014) · UC San Diego · doi:10.7270/q2bv7j3z
Small Molecules Targeting TrkB/BDNF for Neurodegenerative Disease Therapeutic Discovery
Venkatesan, R., Paustian, M. P., Simeon, P., & Trippier, P. C. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00313
Zhang, J., Yu, D., Yang, Z., Zhang, Y., Yang, X., Hou, B., Chen, J., Wang, S. L., Hou, W., Zhang, Y.-X., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.79338
Metadata
- Authors
- Cazorla, M., Prémont, J., Mann, A., Girard, N., Kellendonk, C., & Rognan, D.
- Affiliations
- Inserm (FR)
- Laboratoire d'Innovation Thérapeutique (FR)
- Columbia University Irving Medical Center (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2011-05-02
- Volume
- 121
- Issue
- 5
- Pages
- 1846-1857
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3083767
- OpenAlex
- W2087102666
- Cited by
- 392
- References
- 50
- Citations by year
- 2026: 32 · 2025: 23 · 2024: 21 · 2023: 21 · 2022: 22 · 2021: 21 · 2020: 39 · 2019: 29 · 2018: 47 · 2017: 22 · 2016: 29 · 2015: 32 · 2014: 19 · 2013: 16 · 2012: 13
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Université de Strasbourg
- Centre National de la Recherche Scientifique
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- TrkB receptor, brain-derived neurotrophic factor, ANA-12, anxiolytic effects, antidepressant effects, mood disorders, anxiety, depression, structure-based virtual screening, BDNF/TrkB signaling
- MeSH terms
- Animals, Antidepressive Agents, Anxiety, Azepines, Behavior, Animal, Benzamides, Brain, Chemistry, Pharmaceutical, Depression, Enzyme-Linked Immunosorbent Assay, Humans, Ligands, Molecular Weight, Neurons, Anti-Anxiety Agents, Drug Design, Signal Transduction, Brain-Derived Neurotrophic Factor, Mood Disorders, Receptor, trkB, Receptor, trkA, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review